Empagliflozin Increases Short-Term Urinary Volume Output in Artificially Induced Syndrome of Inappropriate Antidiuresis

Table 2

Number of participants who experienced symptoms attributable to hyponatremia during the study with the according average score of symptom severity on visual analogue scale in brackets (range 0 = no symptoms to 10 = severe symptoms).

Symptoms	Empagliflozin	Placebo
Thirst	9 (2.4)	7 (2.9)	0.51
Headache	10 (2.4)	11 (1.7)	0.75
Nausea	7 (3.1)	6 (3.0)	0.67
Vertigo	6 (2.6)	3 (2.5)	0.50
General malaise	7 (2.8)	5 (3.0)	0.94